Onvatilimab (JNJ-61610588) is a human IgG1 kappa-anti-Vista (T-cell-activated V-domain Ig inhibitor) monoclonal antibody. Onvatilimab has antitumor activity and can be used to treat advanced head and neck cancers.
CAS Number:
[1969313-51-6]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted